Shares of Verra Mobility Corporation plunged about 71 percent in Wednesday morning trading, likely due to yesterday's announcement regarding a contract termination notice from Avis Budget Group and the company's revised outlook for full-year 2026. The company's stock is currently trading at $3.7550,...
Stock of Eva Live, Inc. (GOAI) is climbing about 10 percent on Wednesday morning after the company announced the execution of a Letter of Intent of Intent with Dermatech Mobile Care, DBA Spiro Senior Care. The company's shares are currently trading at $3.76 on the Nasdaq, up 10.76 percent. The stock...
Shares of AMASS Brands, Inc. (AMSS) are surging about 85 percent in Wednesday morning trading after the company's Good Twin brand reserved the first spot in organic non-alcoholic wine market in the United States based on dollar share, according to Nielsen. The company's shares are currently trading...
Wednesday, Ironwood Pharmaceuticals, Inc. (IRWD) announced that the U.S. Food and Drug Administration has approved the use of LINZESS, also known as linaclotide, in pediatric patients 2 years of age and older with functional constipation. With this approval, LINZESS remains the only FDA-approved prescription...
Monro, Inc. (MNRO), a provider of automotive repair and tire services, on Wednesday reported a reduced net loss for the fourth quarter, with narrowed operating loss cushioning the impact of declining revenue. For the quarter ended March net loss reduced 69.1 percent, to $6.58 million or $0.23 per...
Wednesday, Akzo Nobel NV (AKU1.MU) confirmed the rejection of a takeover proposal from Nippon Paint Holdings Co. (NI7.F), and The Sherwin-Williams Company received on April 29, 2026, to buy all issued and outstanding shares of the company at an offer price of 73 euros per share in cash. The proposal...
Rollins, Inc. (ROL), a consumer and commercial services company, announced Wednesday that Kenneth Krause, Executive Vice President and Chief Financial Officer, will resign to pursue an opportunity with a company in an unrelated industry, effective June 15, 2026. Krause has agreed to a transition services...
Wednesday, Lululemon Athletica Inc. (LULU) announced a cooperation agreement with Dennis J. "Chip" Wilson, who owns approximately 8.7% of the company's outstanding common stock. As per the agreement, Laura Gentile, former Chief Marketing Officer of ESPN, and Marc Maurer, former Co-Chief Executive...
TG Therapeutics, Inc. (TGTX) on Wednesday reported positive topline results from its Phase 3 ENHANCE study evaluating a single-infusion initiation regimen for BRIUMVI in adults with relapsing forms of multiple sclerosis. The study achieved its primary endpoint, showing bioequivalent drug exposure...
Manchester United (MANU) posted a third quarter net loss of 11.8 million pounds compared to a loss of 2.7 million pounds, a year ago. Basic loss per share was 6.83 pence compared to a loss of 1.57 pence. Adjusted EBITDA was 84.7 million pounds, up 65.4%. Adjusted basic profit per share was 2.95 pence...
Dycom Industries, Inc. (DY), on Wednesday, reported higher net income in the first quarter compared with the previous year. For the first quarter, net income increased to $91.29 million from $61.05 million in the previous year. Earnings per share were $3 versus $2.09 last year. On the adjusted...
Global pharmaceutical solutions provider Cencora, Inc. (COR) Wednesday announced the appointment of Eva Boratto as executive vice president and chief financial officer, effective June 29, 2026. Boratto will succeed James Cleary, who will be retiring as previously announced and will serve in an advisory...
Stratasys Ltd. (SSYS) said on Wednesday it agreed to acquire Markforged in an all-cash deal valued at $42.5 million, as the 3D printing firm looks to strengthen its position in defense and aerospace. The acquisition will add Markforged's continuous carbon fiber technology and The Digital Forge software...
Apogee Therapeutics, Inc. (APGE) on Wednesday announced a financing partnership with Blackstone Life Sciences that could provide up to $1.3 billion in non-dilutive capital to help advance and potentially commercialize its lead drug candidate, zumilokibart. The deal includes as much as $800 million...
Apogee Therapeutics, Inc. (APGE), a clinical-stage biotechnology company, announced Wednesday positive 16-week data from Part B of the Phase 2 APEX clinical trial of zumilokibart (APG777), a potential best-in-class anti-IL-13 antibody, in patients with moderate-to-severe AD. The trial met all its...
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.